Ascendis Pharma A/S - American Depositary Shares — Cash Flow (NASDAQ:ASND) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities —————— — Cash from investing activities —————— — Cash from financing activities —————— — Free cash flow —————— —

新闻

FDA批准Ascendis每周一次的软骨发育不全症治疗药物

FDA approves Ascendis’ once-weekly achondroplasia treatment

Ascendis Pharma安排年度股东大会并发布2025年报告

Ascendis Pharma schedules annual meeting and releases 2025 reports

RBC Capital重申Ascendis Pharma评级,看好Yorvipath增长势头

RBC Capital reiterates Ascendis Pharma stock rating on Yorvipath momentum

Cantor Fitzgerald上调Ascendis Pharma目标价至300美元，看好CNP产品线前景

Cantor Fitzgerald raises Ascendis Pharma stock price target to $300 on CNP franchise outlook

Stifel上调Ascendis Pharma目标价至325美元，看好Yorvipath增长

Stifel raises Ascendis Pharma stock price target to $325 on Yorvipath growth

Baird maintains BioMarin stock rating amid competitor’s positive trial data

BioMarin和Ascendis股价因BridgeBio强劲的软骨发育不全数据而下跌